Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 8.3% in July

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) saw a significant decline in short interest in July. As of July 31st, there was short interest totalling 13,200 shares, a decline of 8.3% from the July 15th total of 14,400 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume […]

Leave a Reply

Your email address will not be published.

Previous post ATB Capital Lowers Tidewater Renewables (TSE:LCFS) Price Target to C$8.00
Next post SunHydrogen (OTCMKTS:HYSR) versus Nextracker (NASDAQ:NXT) Head-To-Head Review